Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics reveals specific biological changes induced by the normothermic machine perfusion of donor kidneys with a significant up-regulation of Latexin. | Sci Rep | 2023 | 37041202 | PubTator, text mining | PubMed |
| Astaxanthin supplementation counters exercise-induced decreases in immune-related plasma proteins. | Front Nutr | 2023 | 37025615 | PubTator, text mining | PubMed |
| Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics. | Front Immunol | 2023 | 37020564 | PubTator, text mining | PubMed |
| Rewiring of miRNA-mRNA bipartite co-expression network as a novel way to understand the prostate cancer related players. | Syst Biol Reprod Med | 2023 | 37018429 | PubTator, text mining | PubMed |
| Serpin family proteins as potential biomarkers and therapeutic drugs in stroke: A systematic review and meta-analysis on clinical/preclinical studies. | CNS Neurosci Ther | 2023 | 37017398 | PubTator, text mining | PubMed |
| Pegcetacoplan: A New Opportunity for Complement Inhibition in PNH. | J Blood Med | 2023 | 37016661 | PubTator, text mining | PubMed |
| SARS-CoV-2 Receptors and Their Involvement in Cell Infection. | Biochem (Mosc) Suppl Ser A Membr Cell Biol | 2023 | 37008884 | PubTator, text mining | PubMed |
| Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target. | Front Immunol | 2023 | 37006238 | PubTator, text mining | PubMed |
| Integrated analysis to identify the prognostic and immunotherapeutic roles of coagulation-associated gene signature in clear cell renal cell carcinoma. | Front Immunol | 2023 | 37006234 | PubTator, text mining | PubMed |
| New insight of complement system in the process of vascular calcification. | J Cell Mol Med | 2023 | 37002701 | PubTator, text mining | PubMed |
| Elucidating the Implications of Norovirus N- and O-Glycosylation, O-GlcNAcylation, and Phosphorylation. | Viruses | 2023 | 36992506 | PubTator, text mining | PubMed |
| MASP3 Deficiency in Mice Reduces but Does Not Abrogate Alternative Pathway Complement Activity Due to Intrinsic Profactor D Activity. | J Immunol | 2023 | 36988282 | PubTator, text mining | PubMed |
| LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1. | Biomolecules | 2023 | 36979356 | PubTator, text mining | PubMed |
| Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2? | Biology (Basel) | 2023 | 36979076 | PubTator, text mining | PubMed |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 | 36973268 | PubTator, text mining | PubMed |
| Severe Laryngeal Edema after Extubation with Prior Use of ACEi Medications. | Kans J Med | 2023 | 36970036 | PubTator, text mining | PubMed |
| Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature. | Front Immunol | 2023 | 36969177 | PubTator, text mining | PubMed |
| Extracellular matrix stiffness-The central cue for skin fibrosis. | Front Mol Biosci | 2023 | 36968277 | PubTator, text mining | PubMed |
| Degradation of collagen I by activated C1s in periodontal Ehlers-Danlos Syndrome. | Front Immunol | 2023 | 36960056 | PubTator, text mining | PubMed |
| Neuronal guidance genes in health and diseases. | Protein Cell | 2023 | 36942388 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=20